Cargando…

Effects and mechanisms of trifluridine alone or in combination with cryptotanshinone in inhibiting malignant biological behavior of gastric cancer

BACKGROUND: The incidence of gastric cancer (GC) ranks fourth among all malignant tumors worldwide, and the fatality rate ranks second among all malignant tumors. Several Chinese traditional medicines have been used in the treatment of advanced gastric cancer. This study aims to investigate the effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Pan-Quan, Zhang, Li-Xiang, Chen, Zhang-Ming, Wang, Gang, Zhu, Hai, Ying, Songcheng, Wei, Zhi-Jian, Han, Wen-Xiu, Xu, A-Man
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281482/ https://www.ncbi.nlm.nih.gov/pubmed/37272203 http://dx.doi.org/10.1080/15384101.2023.2215678

Ejemplares similares

A phase 1 study of the pharmacokinetics of nucleoside analog trifluridine and thymidine phosphorylase inhibitor tipiracil (components of TAS-102) vs trifluridine alone
por: Cleary, James M., et al.
Publicado: (2017)

Trifluridine/Tipiracil: A Review in Metastatic Gastric Cancer
por: Kang, Connie, et al.
Publicado: (2019)

Cryptotanshinone induces ROS-mediated apoptosis in human gastric cancer cells
por: Liu, Chang, et al.
Publicado: (2017)

Correction to: Trifluridine/Tipiracil: A Review in Metastatic Gastric Cancer
por: Kang, Connie, et al.
Publicado: (2019)

Cryptotanshinone ameliorates CUS-induced depressive-like behaviors in mice
por: Wang, Kaixin, et al.
Publicado: (2021)

Cryptotanshinone inhibits cytotoxin-associated gene A-associated development of gastric cancer and mucosal erosions
por: Chen, Zhang-Ming, et al.
Publicado: (2021)

Biomarkers of Trifluridine-Tipiracil Efficacy
por: Voutsadakis, Ioannis A.
Publicado: (2021)

Cryptotanshinone Attenuated Pathological Cardiac Remodeling In Vivo and In Vitro Experiments
por: Li, Wen-jing, et al.
Publicado: (2023)

Novel perspectives on the therapeutic role of cryptotanshinone in the management of stem cell behaviors for high-incidence diseases
por: Guo, Xiaomeng, et al.
Publicado: (2022)

Extension of the European Medicines Agency (EMA) approval of trifluridine/tipiracil for gastric cancer
por: Alsina, Maria, et al.
Publicado: (2019)

Genome-Wide Transcriptional Profiling of the Response of Staphylococcus aureus to Cryptotanshinone
por: Feng, Haihua, et al.
Publicado: (2009)

Efficacy and outcome of extensive intraoperative peritoneal lavage plus surgery vs surgery alone with advanced gastric cancer patients
por: Song, En-Dong, et al.
Publicado: (2023)

Monitoring trifluridine incorporation in the peripheral blood mononuclear cells of colorectal cancer patients under trifluridine/tipiracil medication
por: Nakanishi, Ryota, et al.
Publicado: (2017)

Pharmacokinetics and tissue distribution of bleomycin-induced idiopathic pulmonary fibrosis rats treated with cryptotanshinone
por: He, Xiangjun, et al.
Publicado: (2023)

Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada
por: Ding, Philip Q., et al.
Publicado: (2022)

Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity
por: Wang, Jiye, et al.
Publicado: (2017)

Ethosomes Loaded with Cryptotanshinone for Acne Treatment through Topical Gel Formulation
por: Yu, Zhenwei, et al.
Publicado: (2016)

The Influence of Selected Factors on the Aqueous Cryptotanshinone Solubility
por: Kobryń, Justyna, et al.
Publicado: (2021)

MicroRNA profiles involved in trifluridine resistance
por: Tsunekuni, Kenta, et al.
Publicado: (2017)

Trifluridine/Tipiracil: Old Drug, New Tricks
por: Jeffers, Kate D.
Publicado: (2016)

Cost-effectiveness of trifluridine/tipiracil against nivolumab for heavily pretreated metastatic gastric cancer in Japan
por: Takushima, Yusuke, et al.
Publicado: (2021)

Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
por: Kotani, Daisuke, et al.
Publicado: (2019)

Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
por: Wu, Pei, et al.
Publicado: (2018)

Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study
por: Chida, Keigo, et al.
Publicado: (2021)

The effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer: A protocol for systematic review and meta-analysis
por: He, Xiaoyan, et al.
Publicado: (2021)

Cryptotanshinone Ameliorates Radiation-Induced Lung Injury in Rats
por: Jiang, Yifang, et al.
Publicado: (2019)

Targeting oncogenic mutations in colorectal cancer using cryptotanshinone
por: Vundavilli, Haswanth, et al.
Publicado: (2021)

Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma
por: Luo, Yi, et al.
Publicado: (2020)

Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer
por: Suzuki, Norihiko, et al.
Publicado: (2017)

Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer
por: Suzuki, Norihiko, et al.
Publicado: (2021)

Cryptotanshinone Alleviates Oxidative Stress and Reduces the Level of Abnormally Aggregated Protein in Caenorhabditis elegans AD Models
por: Cui, Wen-Bo, et al.
Publicado: (2022)

Cryptotanshinone attenuates LPS-induced acute lung injury by regulating metabolic reprogramming of macrophage
por: Ye, Zesen, et al.
Publicado: (2023)

Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)
por: Takahashi, Naoki, et al.
Publicado: (2023)

Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression
por: Matsuoka, Kazuaki, et al.
Publicado: (2018)

Clinical Evaluation of the Safety and Efficacy of Trifluridine/Tipiracil in the Treatment of Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Evidence to Date
por: Wheelden, Megan, et al.
Publicado: (2020)

Real-World Data of Trifluridine/Tipiracil for Patients With Advanced Gastric Cancer: A Multi-Institutional Retrospective Study
por: Matsumoto, Toshihiko, et al.
Publicado: (2022)

Preparation and optimization of surface stabilized cryptotanshinone nanocrystals with enhanced bioavailability
por: Zhao, Wenzheng, et al.
Publicado: (2023)

Development of cryptotanshinone-loaded pellets for angina chronotherapy: In vitro/in vivo prediction and evaluation()
por: Li, Zhenghua, et al.
Publicado: (2018)

Cytotoxicity of trifluridine correlates with the thymidine kinase 1 expression level
por: Kataoka, Yuki, et al.
Publicado: (2019)

Cryptotanshinone possesses therapeutic effects on ischaemic stroke through regulating STAT5 in a rat model
por: Zhu, Feihong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j1fqov3j2t287oas9hdl0o56j4